Flagstaff Medical Center receives $167,400 grant from AstraZeneca HealthCare Foundation
Flagstaff Medical Center (FMC) recently received a $167,400 grant from the AstraZeneca HealthCare Foundation. The grant was awarded through the foundation’s Connections for Cardiovascular HealthSM program and will be used to create and fund the Northern Arizona Diabetes – Heart Connection program. FMC is one of only 24 organizations nationwide to receive funds through the Connections for Cardiovascular HealthSM program since its launch in 2010. The program supports innovative work in the field of cardiovascular health.
The Northern Arizona Diabetes – Heart Connection program is aimed at under-served, low-income Native Americans who are at risk of developing cardiovascular disease and/or diabetes. Grant funds will be used to improve wellness and overall health by identifying, screening and educating those at risk for diabetes and cardiovascular disease. The 2001 National Institute of Health Strong Heart Study showed Native American participants with diabetes were four times more likely to experience heart failure than participants without diabetes.
“We are honored to be working with the AstraZeneca HealthCare Foundation to positively impact the health of those most at risk for heart disease and diabetes,” said William Bradel, F.A.C.H.E., Flagstaff Medical Center president and CEO. “Our mission is to transform the health of the communities we serve. This grant will help us offer resources, education and support in outlying areas with limited healthcare resources.”
The Northern Arizona Diabetes – Heart Connection program is a collaboration between FMC, North Country HealthCare and Native Americans for Community Action. The new program will be integrated with and extend the reach of existing diabetes education and management programs in the area. Heart Connection is part of Diabetes Together, a regional community health initiative being facilitated by Flagstaff Medical Center and Northern Arizona Healthcare.
Heart Connection services will include identifying persons at risk for pre-diabetes using the American Diabetes Association recommendations; assessing for cardiovascular disease risk through a heart-health screening; providing an introductory visit with a certified diabetes educator and/or a registered dietitian; and developing a customized, culturally-competent plan to best address each person's individual needs.
“We must work to decrease the risk of and prevent cardiovascular disease in the United States, by providing resources to those who are in need,” said Timothy J. Gardner, M.D., trustee, AstraZeneca HealthCare Foundation. “Flagstaff Medical Center is providing an innovative program to improve cardiovascular health across Northern Arizona.”
FMC is a non-profit subsidiary of Northern Arizona Healthcare. As Northern Arizona’s only regional referral center, FMC cares for more than 85,000 patients each year. With more than 200 active-staff physicians and approximately 2,000 employees, FMC provides comprehensive, state-of-the-art healthcare from diagnostic outpatient services to open heart surgery. Additionally, FMC is Arizona’s only Level I Trauma Center and Pediatric Intensive Care Unit north of Phoenix. To learn more about programs and services offered at Flagstaff Medical Center, visit FlagstaffMedicalCenter.com.
Established in 1993, the AstraZeneca HealthCare Foundation is a Delaware not-for-profit corporation and a 501(c)(3) entity organized for charitable purposes including to promote public awareness of healthcare issues, to promote public education of medical knowledge and to support or contribute to charitable and qualified exempt organizations consistent with its charitable purpose. Organizations can learn more and apply online for a Foundation grant at http://www.astrazeneca-us.com/foundation.